1,467 results on '"Bartlett, David L."'
Search Results
252. Aggressive Locoregional Management of Recurrent Peritoneal Sarcomatosis
253. Development of a replication-selective, oncolytic poxvirus for the treatment of human cancers
254. Factors Affecting Survival After Complete Response to Isolated Limb Perfusion in Patients With In-Transit Melanoma
255. A Prospective Study of 2-[18F] Fluoro-2-Deoxy-D-Glucose/Positron Emission Tomography Scan, 99mTc-Labeled Arcitumomab (CEA-Scan), and Blind Second-Look Laparotomy for Detecting Colon Cancer Recurrence in Patients With Increasing Carcinoembryonic Antigen Levels
256. Mucin as a therapeutic target in pseudomyxoma peritonei
257. A Prospective Analysis of Plasma Endostatin Levels in Colorectal Cancer Patients With Liver Metastases
258. Vaccinia as a vector for tumor-directed gene therapy: Biodistribution of a thymidine kinase-deleted mutant
259. Critical role of hyperthermic intraperitoneal chemoperfusion in the treatment of a patient with Pseudomyxoma peritonei
260. The current state of robotic-assisted pancreatic surgery
261. Isolated Organ Perfusion Does Not Result in Systemic Microembolization of Tumor Cells
262. Management of Extremity Recurrences After Complete Responses to Isolated Limb Perfusion in Patients With Melanoma
263. Treatment of Primary Peritoneal Mesothelioma by Continuous Hyperthermic Peritoneal Perfusion (CHPP)
264. Thrombocytopenia After Isolated Limb or Hepatic Perfusions with Melphalan: The Risk of Heparin-Induced Thrombocytopenia
265. A pilot phase I trial of continuous hyperthermic peritoneal perfusion with high-dose carboplatin as primary treatment of patients with small-volume residual ovarian cancer
266. C-stage in Colon Cancer: Implications of Carcinoembryonic Antigen Biomarker in Staging, Prognosis, and Management
267. Robotic-Assisted Major Pancreatic Resection and Reconstruction
268. Activation of the phosphoinositide-3-kinase and mammalian target of rapamycin signaling pathways are associated with shortened survival in patients with malignant peritoneal mesothelioma
269. 2020 SSO Presidential Address: Surgical Oncology Moonshot
270. Significance of Uncinate Duct Dilatation in IPMNs
271. Changes in Performance of More Than 1000 Minimally Invasive Liver Resections
272. KRAS amplification in metastatic colon cancer is associated with a history of inflammatory bowel disease and may confer resistance to anti-EGFR therapy
273. Synergistic apoptosis following endoplasmic reticulum stress aggravation in mucinous colon cancer
274. BAX-dependent mitochondrial pathway mediates the crosstalk between ferroptosis and apoptosis
275. Oncolytic virus promotes tumor-reactive infiltrating lymphocytes for adoptive cell therapy
276. Better Biomarkers for Surgeons Treating Cancer
277. A Randomized Phase II Preoperative Study of Autophagy Inhibition with High-Dose Hydroxychloroquine and Gemcitabine/Nab-Paclitaxel in Pancreatic Cancer Patients
278. Long‐term survival following minimally invasive extended cholecystectomy for gallbladder cancer: A 7‐year experience from the National Cancer Database
279. 100 PROACTIVE EUS-GUIDED FINE-NEEDLE ASPIRATION AND/OR BIOPSY (EUS-FNA/B) TISSUE COLLECTION IN PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) ALLOWS FOR COMPREHENSIVE GENOMIC PROFILING (CGP)
280. 664 PROACTIVE EUS-GUIDED FINE-NEEDLE ASPIRATION AND/OR BIOPSY (EUS-FNA/B) TISSUE COLLECTION IN PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) ALLOWS FOR COMPREHENSIVE GENOMIC PROFILING (CGP)
281. 105 TARGETED NEXT-GENERATION SEQUENCING (NGS) OF BILIARY BRUSHINGS AND BIOPSIES IMPROVES THE DETECTION OF MALIGNANT STRICTURES AND POTENTIALLY STRATIFIES PATIENTS FOR TARGETED ANTICANCER THERAPY
282. In Situ Therapeutic Cancer Vaccination with an Oncolytic Virus Expressing Membrane-Tethered IL-2
283. Sa1396 NEXT-GENERATION SEQUENCING OF PANCREATIC CYST FLUID IS BOTH SENSITIVE AND SPECIFIC FOR THE CLASSIFICATION OF NEOPLASTIC CYSTS AND THE DETECTION OF ADVANCED NEOPLASIA IN INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS: A PROSPECTIVE MULTI-INSTITUTIONAL STUDY
284. 428 TARGETED NEXT-GENERATION SEQUENCING (NGS) OF BILIARY BRUSHINGS AND BIOPSIES IMPROVES THE DETECTION OF MALIGNANT STRICTURES AND POTENTIALLY STRATIFIES PATIENTS FOR TARGETED ANTICANCER THERAPY
285. Global Forum of Cancer Surgeons: Position Statement to Promote Cancer Surgery Globally
286. Synergistic Combination of Oncolytic Virotherapy and Immunotherapy for Glioma
287. Long‐term oncologic outcomes of robotic and open pancreatectomy in a national cohort of pancreatic adenocarcinoma
288. A Real-Time Mobile Intervention to Reduce Sedentary Behavior Before and After Cancer Surgery: Usability and Feasibility Study
289. Oncolytic vaccinia virus delivering tethered IL-12 enhances antitumor effects with improved safety
290. Recurrent Rearrangements in PRKACA and PRKACB in Intraductal Oncocytic Papillary Neoplasms of the Pancreas and Bile Duct
291. Ferroptotic agent‐induced endoplasmic reticulum stress response plays a pivotal role in the autophagic process outcome
292. Deciphering the Molecular Landscape of Appendiceal Mucinous Neoplasms for Diagnostic, Prognostic and Therapeutic Purposes
293. Rational application of targeted therapeutics in mucinous colon/appendix cancers with positive predictive factors
294. Stabilization Policy in Post-Soviet Armenia
295. Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis
296. Establishment and characterization of a murine xenograft model of appendiceal mucinous adenocarcinoma
297. Time to Surgery and Colon Cancer Survival in the United States
298. 500 Minimally Invasive Robotic Pancreatoduodenectomies
299. A Real-Time Mobile Intervention to Reduce Sedentary Behavior Before and After Cancer Surgery: Usability and Feasibility (Preprint)
300. HIPEC: The Complexities of Clinical Trials
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.